Which of the following is a component of patient advocacy

Anurse is teaching a client who is to begin cyclophosphamide therapy to treat cancer. which of the following adverse effects of this medication should the nurse include in the teaching? a. hypotension b. bradycardia c. hyperglycemia d. leukopenia

Anurse is assessing a client who receives monthly injections of cyanocobalamin. which of the following findings indicates a therapeutic effect of the medication? a. absence of hand tremors b. hematocrit 45% c. potassium 3.8 meq/l d. improved appetite

Anurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. for which of the following data, discovered after the medication was administered, should the nurse consider filling an incident report? a. the client had chemotherapy 12 hr before the medication was administered. b. the nurse flushed the client’s iv line with d5w before and after the medication was administered. c. the client’s absolute neutrophil count was 2,500/mm^3 before the medication was administered. d. the medication vial sat at the room temperature for 2 hr before it was administered.